IOM Panel Ends California Visit With No Mainstream Media Coverage
The blue-ribbon Institute of Medicine panel examining the performance of the $3 billion California stem cell agency has quietly concluded its first public hearing in California without so much as a smidgen of daily coverage in the mainstream media.
Instead, the big state news in California yesterday was a lawsuit filed by lawmakers against the state's to…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.